COMMUNIQUÉS West-GlobeNewswire

Bluesight Launches Prism Assistant in PrivacyPro, Bringing AI-Powered Investigations to Patient Privacy Teams
14/10/2026
Alexandria, VA,, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prism Assistant helps privacy teams accelerate investigations, reporting, and analysis – while keeping sensitive patient access data secure. Bluesight, the leader in [...]
iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch
14/10/2026
NASHVILLE, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced the appointment of Donnie Purto as Senior Vice President of Sales to lead the company’s [...]
GeneCentric Announces Oral Presentation at ASHG 2026 Highlighting Fragmentomics-based ExpressCT™ Liquid Biopsy Technology
14/10/2026
DURHAM, N.C., Oct. 14, 2026 (GLOBE NEWSWIRE) -- GeneCentric , a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present at the American [...]
Immutep and Monash University Secure Further ARC Linkage Projects Funding for LAG-3 Research
14/10/2026
SYDNEY, AUSTRALIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel immunotherapies for cancer and [...]
Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise
14/10/2026
BRISBANE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company developing in vivo CAR-T therapies designed to reset dysfunctional [...]
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
14/10/2026
New Innovations Designed to Advance Patient-Specific Planning and Connected Surgical Workflows AUDUBON, Pa., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology [...]
Alignment Healthcare to Announce Third Quarter 2026 Financial Results and Host Conference Call Thursday, Oct. 29, 2026
14/10/2026
ORANGE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its third quarter 2026 financial results on Thursday, Oct. 29, 2026, after market close. Following the release, [...]
PRG Partners with Devsinc to Build the Digital Foundation for Scalable Growth with Microsoft Dynamics 365
14/10/2026
Multi-phase transformation unifies sales, service, finance, and client experience on a single enterprise platform across PRG and its family of companies DOWNERS GROVE, Ill., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Physicians [...]
Jushi Holdings Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
14/10/2026
BOCA RATON, Fla., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSH ) , a vertically integrated, multi-state cannabis operator, announced that it expects to [...]
La Fondation du CUSM lance le Cercle pour la santé des femmes afin d’accélérer les progrès en santé des femmes
14/10/2026
Un nouveau mouvement philanthropique vise à réunir 500 femmes pour faire avancer la recherche et les soins en santé des femmes, en s’appuyant sur un premier appui financier important et six projets porteurs déjà en [...]
The MUHC Foundation launches the Women’s Health Circle to accelerate progress in women’s health
14/10/2026
A new philanthropic movement is bringing together 500 women to advance research and care in women’s health, building on strong early support and six transformative projects already underway MONTREAL, Oct. 14, 2026 ( [...]
CAMP4 to Participate in Chardan’s 10th Annual Healthcare Conference
14/10/2026
WATERTOWN, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics [...]
Tvardi Therapeutics to Participate in Chardan’s 10th Annual Healthcare Conference
14/10/2026
HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule [...]
Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London
14/10/2026
PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for type 1 diabetes ( [...]
BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026
14/10/2026
MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, [...]
MaxCyte Reports Preliminary Third Quarter 2026 Revenue and Raises Full Year 2026 Revenue Guidance
14/10/2026
MaxCyte will host its third quarter 2026 earnings conference call on November 10, 2026 ROCKVILLE, Md., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading cell-engineering company providing [...]
CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
14/10/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 14, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company") today notes the announcement from Sarborg Limited regarding intellectual property [...]
Sapreme Therapeutics announces oral presentation of new preclinical data on lead Duchenne muscular dystrophy candidate SPM-2551 at OTS 2026
14/10/2026
SPM-2551 demonstrated robust and durable pharmacological activity following a single low-dose administration in preclinical Duchenne muscular dystrophy (DMD) models Data support Sapreme's proprietary SPT platform, [...]
Nxera Pharma Enters into Exclusive License, Supply and Commercialization Agreement with Synmosa for QUVIVIQ® (daridorexant) Across Eight Asia-Pacific Markets
14/10/2026
Synmosa to lead regulatory approvals, market access, distribution and sales in Singapore, Thailand, Indonesia, Malaysia, the Philippines, Vietnam, Australia and New Zealand. Nxera to supply drug product and receive an [...]

Pages